IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-08390-z.html
   My bibliography  Save this article

The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma

Author

Listed:
  • Vivek Bhaskaran

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Michal O. Nowicki

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Mahmoud Idriss

    (Harvard Medical School and Brigham and Women’s Hospital
    Northeastern University)

  • Miguel A. Jimenez

    (Harvard Medical School and Brigham and Women’s Hospital
    University of Central Florida)

  • Gianmarco Lugli

    (Harvard Medical School and Brigham and Women’s Hospital
    Universita’ Cattolica del Sacro Cuore)

  • Josie L. Hayes

    (University of California, Berkeley)

  • Ahmad Bakur Mahmoud

    (Harvard Medical School and Brigham and Women’s Hospital
    Taibah University)

  • Rachel E. Zane

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Carmela Passaro

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Keith L. Ligon

    (Brigham and Women’s Hospital)

  • Daphne Haas-Kogan

    (Dana-Farber Cancer Institute)

  • Agnieszka Bronisz

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Jakub Godlewski

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Sean E. Lawler

    (Harvard Medical School and Brigham and Women’s Hospital)

  • E. Antonio Chiocca

    (Harvard Medical School and Brigham and Women’s Hospital)

  • Pierpaolo Peruzzi

    (Harvard Medical School and Brigham and Women’s Hospital)

Abstract

MicroRNA deregulation is a consistent feature of glioblastoma, yet the biological effect of each single gene is generally modest, and therapeutically negligible. Here we describe a module of microRNAs, constituted by miR-124, miR-128 and miR-137, which are co-expressed during neuronal differentiation and simultaneously lost in gliomagenesis. Each one of these miRs targets several transcriptional regulators, including the oncogenic chromatin repressors EZH2, BMI1 and LSD1, which are functionally interdependent and involved in glioblastoma recurrence after therapeutic chemoradiation. Synchronizing the expression of these three microRNAs in a gene therapy approach displays significant anticancer synergism, abrogates this epigenetic-mediated, multi-protein tumor survival mechanism and results in a 5-fold increase in survival when combined with chemotherapy in murine glioblastoma models. These transgenic microRNA clusters display intercellular propagation in vivo, via extracellular vesicles, extending their biological effect throughout the whole tumor. Our results support the rationale and feasibility of combinatorial microRNA strategies for anticancer therapies.

Suggested Citation

  • Vivek Bhaskaran & Michal O. Nowicki & Mahmoud Idriss & Miguel A. Jimenez & Gianmarco Lugli & Josie L. Hayes & Ahmad Bakur Mahmoud & Rachel E. Zane & Carmela Passaro & Keith L. Ligon & Daphne Haas-Koga, 2019. "The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma," Nature Communications, Nature, vol. 10(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08390-z
    DOI: 10.1038/s41467-019-08390-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-08390-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-019-08390-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08390-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.